There are new medical discoveries each day. At DNA Health we strive to bring our patients the very latest in medical discoveries and treatments

There are new medical discoveries each day and our knowledge of longevity is always developing and growing.  Although we have not discovered the fountain of youth yet, at DNA Health we strive to provide our patients the latest and most effective treatments. 

To ensure that we are always ahead of the curve we have assembled an exceptional Global Scientific Board (“GSB”), who have been carefully selected based on their medical knowledge and expertise.

Our GSB meets four times a year with a simple mission to help guide DNA Health in the development, adoption and implementation of cutting-edge preventative care and longevity protocols, ethical practices, and patient-centric solutions.


Dr Nas Al Jafari

DNA Health & Wellness
Group Medical Director
Co-Founder & Chairman of Global Scientific Board

Health and wellness has been Dr Al Jafari’s passion and at the forefront of his medical practice since the early years of his career. He quickly became disillusioned in mainstream medicine by the perpetual cycle of sicker patients and more medications. Through advanced alternative training, he began to appreciate the root causes of disease, and the underlying importance of lifestyle in the etiology of modern illness. It is his integrative approach to health, transcending beyond the field of traditional medicine, which provides patients with true holistic care.

Dr Al Jafari is originally form the UK where he worked as a Consultant Physician and Member of the Royal College of General Practitioners. Having moved over the UAE in 2015 and based now in Dubai, he is the Medical Director of DNA Health Clinic. Dr Al Jafari’s particular focus is in modifying lifestyle factors, optimizing long-term health and prevention of chronic disease. He offers a broad scope of cutting edge treatment strategies for both adults and children, ranging from diabetes and obesity through to autism and dementia.

‘The Doctor of the future will give no medicine, but will instruct his patients in lifestyle and in the cause and prevention of disease

Sho is veteran investment banker, having spent over 20 years working in M&A investment banking, advising on a broad range of complex corporate transactions. 

Sho first became interested in preventative health following some of his own health concerns. He found that Medicine today is almost entirely reactive. Doctors, specialists, and hospitals focus on diagnosis of diseases rather than prevention.

He co-founded DNA Health & Wellness in 2017, with a mission to detect chronic diseases at their earliest stages and provide effective healthcare plans to treat illnesses before they can ever cause harm, giving patients control of their health throughout their life.

Under Sho’s leadership DNA Health has become the leading health optimisation & longevity clinic in the middle east, growing 30x in less than 5 years. 

Today, Sho is avid biohacker and has a deep and practical understanding of the latest developments preventative and longevity medicine. 

Shohidul's profile

Sho Choudhury

DNA Health & Wellness
Chairman, Group CEO and


Chris Moore

CEO, Nordic Group

Chris is co-founder and CEO of Nordic Group. After moving from the UK to Denmark in 1994 he has dedicated his entire career to changing the healthcare narrative and advancing the emergence of personalised medicine around the world.

Nordic Group have supported personalised medicine practitioners in developing their practice, prescribing and protocols for the last 25 years. It began with the foundation of Nordic Laboratories – the first fully focused functional medicine laboratory business in Europe. This led to the launch of Nordic Clinic in 2002 which has now grown into a network of 7 clinics across Europe, with launch plans for a further 15 clinics. The group also now includes significant investments in a range of other companies dedicated to changing the healthcare narrative including Nordic Health, dnalife, Resistomap, Dsruptive, Thermocheck and Økolyst.

The years of experience gained through working at the frontline of clinical practice in our own clinics and in working with practitioners around the globe, helping them to integrate functional and genetic testing into their own practice, led to the foundation of NordicVMS. Launched in 2007 this is designed from the ground up around the needs of practitioners. It is designed to help them better manage their patients, practice, and their time. It manages the entire prescribing process from laboratory testing to results to prescribing supplements, dealing with all of the logistics, payments and administration for the practitioner. NordicVMS has over 100,000 users in more than 80 countries. More than just technology, it’s a complete system of support for the practitioner.

Dr. Claudia Vollbracht, an esteemed member of the scientific board at DNA Health, is a visionary medical advisor whose remarkable journey is a testament to her unwavering commitment to advancing healthcare through the lens of science. 

Born on September 24, 1968, in Hanover, Lower Saxony, Germany, Dr. Vollbracht’s academic odyssey commenced at the prestigious Philipps University Marburg, where she pursued a Master of Science degree in Human Biology from 1988 to 1994.

With a thirst for knowledge and an aspiration to redefine healthcare, Dr. Vollbracht embarked on an enriching academic expedition. She obtained a Master of Science degree in Naturopathy and Complementary Medicine from the esteemed Fresenius University of Applied Sciences, Idstein, spanning the years 2014 to 2016.

Driven by an unwavering dedication to the betterment of healthcare, Dr. Vollbracht pursued doctoral studies with fervuor. From 2018 to 2021, she was immersed in the world of Naturopathy at the University Medical Centre Rostock, under the guidance of the esteemed Chair of Naturopathy

Dr. Vollbracht’s professional voyage has been marked by her longstanding association with Pascoe pharm. Preparations GmbH, located in Gießen, Germany. She commenced her journey in 1995 and has been an instrumental part of the team since 2000, where she plays a pivotal role in the esteemed Medical Science Department.

In recognition of her contributions to the world of science, Dr. Vollbracht is a distinguished member of the Society for Applied Vitamin Research e.V. Her dedication to research is underlined by her authorship of 14 peer-reviewed publications, a testament to her profound impact on the field of medical science.

As a member of the scientific board at DNA Health, Dr. Claudia Vollbracht continues to shape the future of healthcare, applying her expertise, knowledge, and unwavering commitment to advancing scientific excellence in the realm of genetics and health. Her remarkable journey serves as a beacon of inspiration to all those dedicated to the pursuit of excellence in the field of science and medicine.


Dr. Claudia Vollbracht

Medical Advisor Medical Science Department at Pascoe pharm. Präparate GmbH


Ryan Smith

Founder of TruDiagnostic

Ryan received a BA in biochemistry from Transylvania University before heading to medical school in 2013. After passing USMLE Step 1, he decided to leave and open up a pharmacy in the United States that focused on peptide synthesis and formulations for pharmaceutical preparations.  That pharmacy, Tailor Made Compounding, became the 4th fastest growing company in healthcare in the US and grew to 80 million in revenue within 3 years.  Through this pharmacy work, Ryan saw the value of preventative medicine.  Many of the physicians Tailor Made served were treating age as a disease and a primary outcome but needed better tools to measure this process. As a result, Ryan exited Tailor Made in 2020 to create TruDiagnostic.

TruDiagnostic is a CLIA certified lab and health data company which specializes in understanding and reporting insights found through Epigenetic methylation data. Since starting in 2020, TruDiagnostic has created the largest private epigenetic database in the world with over 15,000 patients tested on the EPIC850k array.  From this dataset, they have created many new algorithms to interpret methylation data including algorithms to predict inflammatory markers, disease diagnosis, telomere length, aging pace, immune cell subsets, cellular replication, and more.  TruDiagnostics has also led research in the field with over 30+ clinical trials investigating the best ways to reverse these markers through diet, lifestyle, and prescription interventions. Currently, TruDiagnostic is working with collaborators from Duke, Harvard, Yale, UCSF, Ohio St. and more to uncover new insights from the methylome.   TruDiagnostic is also the only commercial company on the market to offer 2nd or 3rd generation aging algorithms which have shown to be more predictive and precise than 1st generation aging clocks.

In addition to his work with pharmaceuticals, Ryan also consults with international pharmacies and has set up pharmacies in Thailand and Mexico.  In addition, Ryan has developed novel supplements and cosmetic formulations with multiple 100M supplement brands and consults with clinics in the cash pay wellness space.

Book your appointment

Book your appointment